Levin, J., J. Wagner, S. Ryazanov, A. Leonov, S. Shi, F. Schmidt, C. Prix, U. Bertsch, G. Mitteregger-Kretzschmar, M. Geissen, T. Hischberger, P. Tavan, J. Pilger, M. Zweckstetter, T. Frank, M. Baehr, J. Weishaupt, M. Uhr, H. Urlaub, U. Teichmann, K. Boetzel, M. Groschup, H. A. Kretzschmar, C. Griesinger and A. Giese: Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor.. In: Movement Disorders 26, Supplement 2 (2011) S21-S21.
Duong, C. V., M. Geissen and H. Rohrer: The developmental expression of vasoactive intestinal peptide (VIP) in cholinergic sympathetic neurons depends on cytokines signaling through LIFR β-containing receptors. In: Development 129, 6, 1387-1396 (2002).
The Max Planck Society does not take any responsibility for the content of this export.